DrugCite
Search

ZADITEN

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Zaditen Adverse Events Reported to the FDA Over Time

How are Zaditen adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Zaditen, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Zaditen is flagged as the suspect drug causing the adverse event.

Most Common Zaditen Adverse Events Reported to the FDA

What are the most common Zaditen adverse events reported to the FDA?

Convulsion
73 (4.18%)
Pyrexia
53 (3.04%)
Somnolence
46 (2.64%)
Loss Of Consciousness
31 (1.78%)
Aspartate Aminotransferase Increase...
30 (1.72%)
Alanine Aminotransferase Increased
28 (1.6%)
Agitation
24 (1.38%)
Diarrhoea
23 (1.32%)
Epilepsy
22 (1.26%)
Blood Alkaline Phosphatase Increase...
21 (1.2%)
Liver Disorder
20 (1.15%)
Show More Show More
Blood Lactate Dehydrogenase Increas...
19 (1.09%)
Overdose
19 (1.09%)
Erythema Multiforme
17 (.97%)
Erythema
16 (.92%)
Febrile Convulsion
16 (.92%)
Pruritus
16 (.92%)
Accidental Overdose
14 (.8%)
Dizziness
14 (.8%)
Haematuria
14 (.8%)
Irritability
14 (.8%)
Malaise
14 (.8%)
Speech Disorder
14 (.8%)
Areflexia
13 (.74%)
Blood Creatine Phosphokinase Increa...
13 (.74%)
Depressed Level Of Consciousness
13 (.74%)
Drug Exposure During Pregnancy
13 (.74%)
Gamma-glutamyltransferase Increased
13 (.74%)
Growth Retardation
13 (.74%)
Pneumonia
13 (.74%)
Toxic Encephalopathy
13 (.74%)
Cough
12 (.69%)
Urticaria
12 (.69%)
Crying
11 (.63%)
Drug Dispensing Error
11 (.63%)
Blood Glucose Increased
10 (.57%)
Mental Retardation
10 (.57%)
Pruritus Generalised
10 (.57%)
Dermatitis Exfoliative
9 (.52%)
Electrocardiogram Qt Prolonged
9 (.52%)
Face Oedema
9 (.52%)
Fall
9 (.52%)
Nasopharyngitis
9 (.52%)
Oedema Peripheral
9 (.52%)
Platelet Count Decreased
9 (.52%)
Syncope
9 (.52%)
Tremor
9 (.52%)
Blister
8 (.46%)
Coarctation Of The Aorta
8 (.46%)
Cystitis
8 (.46%)
Fatigue
8 (.46%)
Feeling Abnormal
8 (.46%)
Gastrointestinal Malformation
8 (.46%)
Headache
8 (.46%)
Oesophageal Atresia
8 (.46%)
Skin Exfoliation
8 (.46%)
Vomiting
8 (.46%)
Abnormal Behaviour
7 (.4%)
Amnesia
7 (.4%)
Condition Aggravated
7 (.4%)
Drug Ineffective
7 (.4%)
Epistaxis
7 (.4%)
Eye Pain
7 (.4%)
Heart Disease Congenital
7 (.4%)
Hepatic Function Abnormal
7 (.4%)
Pallor
7 (.4%)
Pollakiuria
7 (.4%)
Rash
7 (.4%)
Abdominal Pain Upper
6 (.34%)
Agranulocytosis
6 (.34%)
Arthralgia
6 (.34%)
Asthenia
6 (.34%)
Asthma
6 (.34%)
Blood Bilirubin Increased
6 (.34%)
Blood Cholesterol Increased
6 (.34%)
Blood Creatinine Decreased
6 (.34%)
Blood Lactate Dehydrogenase Decreas...
6 (.34%)
Blood Pressure Decreased
6 (.34%)
C-reactive Protein Increased
6 (.34%)
Cheilitis
6 (.34%)
Cyanosis
6 (.34%)
Cystitis Haemorrhagic
6 (.34%)
Disturbance In Attention
6 (.34%)
Eye Irritation
6 (.34%)
Feeling Hot
6 (.34%)
Generalised Erythema
6 (.34%)
Hallucination, Visual
6 (.34%)
Hepatic Enzyme Increased
6 (.34%)
Hyperhidrosis
6 (.34%)
Lymphocyte Count Decreased
6 (.34%)
Nausea
6 (.34%)
Neutrophil Count Increased
6 (.34%)
Ocular Hyperaemia
6 (.34%)
Palpitations
6 (.34%)
Petechiae
6 (.34%)
Salivary Hypersecretion
6 (.34%)
Skin Irritation
6 (.34%)
Staphylococcal Infection
6 (.34%)
Thrombocytopenia
6 (.34%)
Abdominal Pain
5 (.29%)
Blood Pressure Increased
5 (.29%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Zaditen, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Zaditen is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Zaditen

What are the most common Zaditen adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Zaditen, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Zaditen is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Zaditen According to Those Reporting Adverse Events

Why are people taking Zaditen, according to those reporting adverse events to the FDA?

Asthma
46
Rhinitis Allergic
43
Dermatitis Atopic
39
Seasonal Allergy
34
Urticaria
34
Drug Use For Unknown Indication
26
Show More Show More
Hypersensitivity
25
Pruritus
24
Conjunctivitis Allergic
17
Product Used For Unknown Indication
14
Eczema
11
Rhinitis
11
Dermatitis
10
Rhinorrhoea
7
Insomnia
7
Eye Pruritus
6
Prophylaxis
6
Nasopharyngitis
5
Rash
5
Diffuse Cutaneous Mastocytosis
5
Otitis Media
5
Eye Allergy
5
Food Allergy
5
Chronic Sinusitis
4
Dermatitis Exfoliative
4
Otitis Media Acute
4
Eye Pain
3
Premedication
3
Pharyngitis
3
Dermatitis Allergic
3
Adenoidal Disorder
2
Bronchitis
2
Eczema Asteatotic
2
Cough
2
Lung Disorder
2
Epistaxis
2
Herpes Zoster
2
Henoch-schonlein Purpura
2
Eye Disorder
2
Urticaria Thermal
2
Rhinitis Seasonal
2
Upper Respiratory Tract Infection
2
Rhinitis Prophylaxis
1
Eye Inflammation
1
Atopy
1
Hereditary Angioedema
1
Gastroenteritis Eosinophilic
1
Wheezing
1
Enterocolitis
1
Gastritis Prophylaxis
1
Immunodeficiency
1

Zaditen Case Reports

What Zaditen safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Zaditen. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Zaditen.